MMP1 and non-small cell lung carcinoma: Our results that show that K exerts its anti NSCLC effects by inhibiting the MMP1 mediated IL-17 signaling pathway, rheumatoid arthritis pathway, and relaxin signaling pathway are consistent with our docking results and MD results.